Numbers aside what would the journal entries be for each date

The information below relates to activities of Pops, Inc. in 2019. Pops starts with the following initial partners: William, Lexi, and Megan. Pops develops, manufactures and sells pharmaceuticals. Below are the transactions for the year-ended 12/31/19. Please prepare the necessary journal entries and adjusting journal entries at the end of 2019, for the following transactions assuming all amounts are paid in cash, unless otherwise stated. October 31 Pops sells 2,000 shares of Doran, Inc. common stock for $52 per share. (JUST THE JOURNAL ENTRIES) November 15 The patent for Pillex is approved by the FDA. Production will start in 2020. (JUST THE JOURNAL ENTRIES) December 31 Pops receives interest from the Ordeal and Cerber bonds and dividends from Orgin. Inc. of $2.25 / share. (JUST THE JOURNAL ENTRIES) December 31 Pops makes their first annual payment to First Federal Bank. (JUST THE JOURNAL ENTRIES)